Koss shares were down 15.4% in premarket trades Monday, putting it on pace to snap a two-day winning streak.
HilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus for infants after a trial missed its main goals.
Guggenheim says the monetization of generative AI “is not happening en masse and is not likely to materialize this year.”
Ubisoft’s strategic pivot towards subscriptions and the release of two new games could boost the French company’s share price, Jefferies analysts said
Not all chip stocks enjoyed the exuberant first-half performance seen by Nvidia — and a Melius Research analyst thinks some notable laggards could be primed for solid rebounds.
Shares of Momentus, which provides satellite transportation and servicing, jumped in premarket trades Monday.
Devon is buying acreage in the Williston Basin, an energy-rich area mostly in Montana, North Dakota and Saskatchewan.
Morphic’s stock rocketed Monday, after the biopharmaceutical company announced an agreement to be acquired by Eli Lilly in a cash deal valued at about $3.2 billion.
